![John D. Mills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John D. Mills
Fondateur chez
Tissupath Pty Ltd.
Profil
John D.
Mills is the founder of Tissupath Pty Ltd. (founded in 2004) and holds the title of Director-Research & Development.
He is currently the Executive Chairman at Cavidi AB and a Non-Executive Director at the Prostate Cancer Foundation of Australia.
In the past, he served as the Non-Executive Chairman at CSL Innovation Pty Ltd. from 1995 to 2003, Independent Non-Executive Director at Avecho Biotechnology Ltd. from 2004 to 2010, Managing Director at ResApp Health Ltd. in 2007, and Managing Director at The Macfarlane Burnet Institute For Medical Research & Public.
He also held the position of Director at Adherium (NZ) Ltd. from 2015 to 2019 and Independent Non-Executive Director at Adherium Ltd. from 2015 to 2019.
Additionally, he was an Investment Committee Member at GBS Venture Partners Pty Ltd. Dr. Mills completed his undergraduate studies at The University of Chicago and Harvard Medical School.
Postes actifs de John D. Mills
| Sociétés | Poste | Début |
|---|---|---|
Cavidi AB
 Cavidi AB Pharmaceuticals: MajorHealth Technology Develops and manufactures IVD tests for detection and monitoring of viral diseases | Président | 26/11/2010 |
Tissupath Pty Ltd.
 Tissupath Pty Ltd. Medical/Nursing ServicesHealth Services Operates as a pathology clinics | Fondateur | 01/01/2004 |
Prostate Cancer Foundation of Australia | Directeur/Membre du Conseil | 10/12/2010 |
Anciens postes connus de John D. Mills
| Sociétés | Poste | Fin |
|---|---|---|
| ADHERIUM LIMITED | Directeur/Membre du Conseil | 21/10/2019 |
Adherium (NZ) Ltd.
 Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Develops digital health technologies that address sub-optimal medication use in chronic disease | Directeur/Membre du Conseil | 18/10/2019 |
| AVECHO BIOTECHNOLOGY LIMITED | Directeur/Membre du Conseil | 24/08/2010 |
| RESP HEAL | Directeur Général | 17/12/2007 |
| ZENYTH THERAPEUTICS LIMITED | Président | 01/01/2003 |
Formation de John D. Mills
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Avecho Biotechnology Ltd.
 Avecho Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical and nutraceutical products | Health Technology |
ResApp Health Ltd.
 ResApp Health Ltd. Packaged SoftwareTechnology Services Develops smart phone medical applications for the diagnosis and management of respiratory disease | Technology Services |
GBS Venture Partners Pty Ltd.
 GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partner seeks investment opportunities in private and public companies located in the United States, New Zealand and primarily in Australia. The firm targets companies operating in the fields of human healthcare, biotechnology, life science, biological/small molecule therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements with an investment size ranging from of USD 10 to 12 million. It takes an active role on the board of directors and acts as a lead investor. It also makes co-investments. | Finance |
The Macfarlane Burnet Institute For Medical Research & Public
 The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services Provides medical research and public health services | Commercial Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cavidi AB
Cavidi AB Pharmaceuticals: MajorHealth Technology Develops and manufactures IVD tests for detection and monitoring of viral diseases | Health Technology |
Adherium (NZ) Ltd.
Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Develops digital health technologies that address sub-optimal medication use in chronic disease | Technology Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prostate Cancer Foundation of Australia | |
Tissupath Pty Ltd.
Tissupath Pty Ltd. Medical/Nursing ServicesHealth Services Operates as a pathology clinics | Health Services |
Adherium Ltd.
 Adherium Ltd. Medical SpecialtiesHealth Technology Develops and manufactures solutions for the pharmaceutical sector | Health Technology |
